Sante Fe Teams up with Argentina Agritech to research the medicinal use of Cannabis

Argentina’s province of Santa Fe is teaming up with national Agricultural technology researchers to delve into the world of medical cannabis. They are setting up a number of research plans and teams to identify, clarify and quantify cannabis medical applications, enabling better treatment and access for all in the province and someday, the country, as well as better production!

The Argentine province of Santa Fe, through the Ministries of Health and of Production, Science and Technology, signed an agreement with the National Institute of Agricultural Technology (INTA) for research on the medicinal use of Cannabis.

The objective of this agreement is to develop scientific evidence on different health problems, which are not addressed by conventional medical treatments, for which Cannabis and its derivatives are increasingly prescribed by doctors.

In addition, it seeks to rigorously clarify the therapeutic applications of the Cannabis plant, as well as its derivatives.

Curious about the progress of medical Cannabis research in Argentina and abroad? Need to stay up to date with research results and hemp news? Download our companion Hemp.IM app today!

Argentina’s Sante Fe Teams up with AgriTech to Research Cannabis

In addition, the research to be completed in Santa Fe seeks to evaluate the efficacy of each therapeutic indication for cannabis. This would promote adequate use and the universalization of access to treatment; to know potential side effects; to establish the safety and limitations for their use, and to promote the care and improvement of the quality of life of the population.

In this regard, the Minister of Production, Science and Technology of the province, Daniel Costamagna, expressed that the signing of this agreement “has a strong interdisciplinary imprint between INTA, LIF and the Santa Fe Ministries of Health and Science for the design, development, and implementation of joint actions in the research and production of medicinal Cannabis”.

Likewise, he added “the work plan will allow training through INTA professionals. In addition, it will create research groups in order to generate experimental trials aimed at an integral, vertical and transversal traceability of the cultivation for therapeutic purposes”.

“This is a first step for the province of Santa Fe to generate technical knowledge to achieve a medicinal quality crop”, finally emphasized Costamagna.

The Whole Process to Guarantee Better Canabis Access in Argentina

For her part, the Minister of Health, Sonia Martorano, highlighted that through inter-ministerial and inter-institutional work, “rigorous research oriented to the development of Cannabis for therapeutic purposes will be carried out in Santa Fe. From the selection of the most suitable seeds, to the selection of technologies and the whole process. That is to say that the Santa Fe will select which cannabis seeds to buy, which will be sown in INTA’s lands and will be under its care”.

“Subsequently – emphasized Martorano – the Ministry of Health, through the LIF, will not only intervene in the fractionation of the drug, which is something it is already doing, but also in the production of pharmacological compounds derived from Cannabis. This is a very important step for people who have some health problem since accessibility and availability in the public sphere will be expanded”.

Finally, the director of the Regional Center of INTA Santa Fe, Alejandro Longo, expressed his enthusiasm and considered that “the signing of the agreement is a first and great step for the cultivation of this plant for medicinal purposes, which will allow formalizing and applying the regulations in force in this regard in an articulated and safe way, between different levels of the State, as it is already being done in other provinces of the country”.

__

(Featured image by Ryan Lange via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Notife , a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.